Navigation Links
Touch Bionics appoints Head of Clinical Advocacy
Date:4/2/2008

Experienced industry professional hired to promote clinical awareness,

support and partnerships in the U.S.

BOSTON, MA and LIVINGSTON, Scotland, April 2 /PRNewswire/ - Touch Bionics, developer of the i-LIMB Hand, the world's first commercially available bionic hand with articulating fingers, today announced that it has hired Karl Lindborg, CPO, as the company's Head of Clinical Advocacy.

Effective immediately, Lindborg will operate out of California, further strengthening Touch Bionics' U.S. presence, with the company having recently expanded its sales, marketing, and support teams in the country.

As head of clinical advocacy, Lindborg's role will be to provide clinical direction for the company in the areas of education and association relations, clinical compatibility of upper extremity systems, as well as public forums and clinical symposia. In addition, Lindborg will be the direct conduit into the company for the clinical community regarding questions, concerns and technical support. He will also support Touch Bionics' product development activities.

"I am particularly impressed with the numerous anatomical degrees of freedom the i-LIMB Hand offers over other hands on the market today. This is what functionality is all about," said Lindborg. "The i-LIMB Hand offers a level of flexibility and dexterity previously unavailable to the patient, Certified Prosthetist or Occupational Therapist working with upper extremity limb deficiencies. I look forward to being a member of the Touch Bionics team and clinically supporting its revolutionary products to fellow prosthetic clinicians and their patient population."

Lindborg has more than a decade of experience as a clinician in the orthotics and prosthetics business, holding a variety of clinical and administrative positions in private clinical setting as well as public institutional settings. Mr. Lindborg is also very active with various political, technological and product development roles. Most recently, he was employed with the Department of Veteran Affairs as Chief of VA Northern California Health Care System's Prosthetic and Orthotic Laboratory. Lindborg holds a Bachelor of Science degree in orthotics and prosthetics from the University of Washington School of Rehabilitation Medicine.

About Touch Bionics

Touch Bionics is a leading developer of advanced upper-limb prosthetics. In 2007, Touch Bionics brought to market the i-LIMB Hand, a first-to-market prosthetic device with five individually powered digits. The company continues to develop leading-edge technologies for the treatment of patients with upper-limb deficiencies. For more information, visit http://www.touchbionics.com

The names of actual companies or products mentioned herein may be the

trademarks of their respective owners.


'/>"/>
SOURCE TOUCH BIONICS
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Touching 418 Billion Lives, Hepatitis Still Presents Significant Threat to Global Health
2. Touching 418 Million Lives, Hepatitis Still Presents Significant Threat to Global Health
3. Touch Bionics expands U.S. presence to meet demand for i-LIMB Hand
4. Touch Bionics adds to sales, marketing, production and design teams
5. China Technology Appoints Deloitte Touche Tohmatsu CPA as Independent Auditor
6. Care to Care Begins Providing Radiology Benefit Management Services to Touchstone Health
7. Touch Bionics signs U.S. distribution agreement with SPS
8. Encision Launches Next Generation of EnTouch(R) Handles for Advanced Laparoscopic Procedures
9. Advanced Bionics Deploys CEVA-TeakLite(TM) DSP Core to Enhance Its Harmony(TM) HiResolution(R) Bionic Ear System
10. BioVex Appoints Dr. Thaddeus Pullano as VP, Quality Assurance
11. Codexis Appoints Singapore Laboratories Managing Director
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... (PRWEB) , ... March 22, 2017 , ... ... up human tissue regeneration from small lab samples to full-size tissues, bones, even ... to establish a vascular system that delivers blood deep into the developing tissue. ...
(Date:3/22/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ... ), a clinical-stage pharmaceutical company focused on ... today that Dr. Miriam Kidron , Oramed,s ... "Oral Insulin for Diabetes Treatment: Bypassing the Roadblock," ... Peptide Therapeutics (OPT) Boston Conference in Cambridge, ...
(Date:3/22/2017)... TORONTO , March 22, 2017 /PRNewswire/ - ... Therapeutics (the "Company" or "Propellon"), a start-up created ... WDR5-targeted anti-cancer therapeutics. FACIT,s investment, combined with non-dilutive ... lead program. The seed funding enables Propellon to ... position the Company for financing and/or entering a ...
(Date:3/22/2017)... ... 2017 , ... Okyanos Cell Therapy has announced Tallahassee, FL will be the ... “Stem Cell Therapy: The Next Phase in the Evolution of Medicine.” As the Bahamas’ ... and Therapy Act, Okyanos maintains a mission to help “no-option” patients and those ...
Breaking Biology Technology:
(Date:3/20/2017)... -- PMD Healthcare announces the release of its new ... (WMS), a remote, real-time lung health monitoring and management ... a Medical Device, Digital Health, and Chronic Care Management ... solutions that empower people to improve their healthcare and ... the first ever personal spirometer, Spiro PD, which was ...
(Date:3/9/2017)... SAN FRANCISCO and MOUNTAIN VIEW, ... Zipongo , "Eating Well Made Simple," and 23andMe ... to help guide better food choices.  Zipongo can now ... only their food preferences, health goals and biometrics, but ... to certain food choices. Zipongo,s personalized food ...
(Date:3/2/2017)... 2, 2017 Summary This report provides ... its partnering interests and activities since 2010. ... Read the full report: ... since 2010 report provides an in-depth insight into the partnering ... On demand company reports are prepared upon purchase ...
Breaking Biology News(10 mins):